Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference
RALEIGH, NC, November 29, 2011 – Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at The Oppenheimer 22nd Annual Healthcare Conference in New York, NY on Tuesday, December 13, 2011 at 1:35 p.m. ET.
Interested parties can access a live audio web cast of the presentation at www.salix.com. A replay of the presentation will be available at the same location.
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in–license late–stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's gastroenterology specialty sales and marketing team.
Salix trades on the NASDAQ Global Select Market under the ticker symbol "SLXP".
For more information, please visit our Website at www.salix.com or contact the Company at 919–862–1000. Follow us on Twitter (@SalixPharma) and Facebook (www.facebook.com/SalixPharma ). Information on our web site is not incorporated in our SEC filings.